JP2013535468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535468A5 JP2013535468A5 JP2013521858A JP2013521858A JP2013535468A5 JP 2013535468 A5 JP2013535468 A5 JP 2013535468A5 JP 2013521858 A JP2013521858 A JP 2013521858A JP 2013521858 A JP2013521858 A JP 2013521858A JP 2013535468 A5 JP2013535468 A5 JP 2013535468A5
- Authority
- JP
- Japan
- Prior art keywords
- iaip
- fraction
- iii
- alcohol
- precipitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36733110P | 2010-07-23 | 2010-07-23 | |
| US61/367,331 | 2010-07-23 | ||
| PCT/US2011/045099 WO2012012773A1 (en) | 2010-07-23 | 2011-07-22 | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013535468A JP2013535468A (ja) | 2013-09-12 |
| JP2013535468A5 true JP2013535468A5 (enExample) | 2014-09-11 |
| JP5830096B2 JP5830096B2 (ja) | 2015-12-09 |
Family
ID=44534634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013521858A Expired - Fee Related JP5830096B2 (ja) | 2010-07-23 | 2011-07-22 | 血漿由来インターα阻害タンパク質（ＩａＩｐ）の製造方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8841248B2 (enExample) |
| EP (1) | EP2596014B1 (enExample) |
| JP (1) | JP5830096B2 (enExample) |
| KR (1) | KR20130093607A (enExample) |
| CN (1) | CN103119058A (enExample) |
| AU (1) | AU2011280907B2 (enExample) |
| BR (1) | BR112013001753A2 (enExample) |
| CA (1) | CA2806645A1 (enExample) |
| CO (1) | CO6680653A2 (enExample) |
| EA (1) | EA201390156A1 (enExample) |
| ES (1) | ES2717177T3 (enExample) |
| MX (1) | MX2013000958A (enExample) |
| SG (1) | SG187599A1 (enExample) |
| WO (1) | WO2012012773A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7932365B2 (en) | 2003-11-08 | 2011-04-26 | Pro Thera Biologics, Llc | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| JP5793076B2 (ja) | 2008-05-28 | 2015-10-14 | プロセラ バイオロジクス， インコーポレイテッド | 血液由来インター−アルファ−阻害タンパク質の調製及び組成物。 |
| US8546548B2 (en) | 2009-05-27 | 2013-10-01 | Baxter International Inc. | Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| EP2596014B1 (en) | 2010-07-23 | 2018-11-28 | Baxalta GmbH | Manufacture of inter-alpha-inhibitor proteins (iaip) from plasma |
| TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱 |
| US9572872B2 (en) | 2012-09-09 | 2017-02-21 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
| US20140206844A1 (en) * | 2013-01-18 | 2014-07-24 | Prothera Biologics | Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material |
| WO2017062536A2 (en) * | 2015-10-06 | 2017-04-13 | Kieu Hoang | A method of manfacturing prothrombin complex concentrate from fraction iii and non-prothrombin complex concentrate from fraction iv |
| CA3036553A1 (en) | 2016-09-13 | 2018-03-22 | Prothera Biologics, Inc. | Methods for treating pulmonary disease using inter-alpha inhibitor proteins |
| KR102587810B1 (ko) | 2017-04-25 | 2023-10-11 | 프로테라 바이오로직스, 인크. | 인터-알파 억제제 단백질을 정량화하는 방법 |
| WO2019086463A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| WO2020086879A1 (en) * | 2018-10-24 | 2020-04-30 | Prothera Biologics, Inc. | Inter-alpha inhibitor proteins and methods of use thereof |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN114096558B (zh) * | 2019-07-04 | 2024-10-01 | 德国杰特贝林生物制品有限公司 | 纯化c1-inh的方法 |
| MX2022011950A (es) * | 2020-03-31 | 2022-10-21 | Takeda Pharmaceuticals Co | Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1. |
| EP4240757A2 (en) * | 2020-11-09 | 2023-09-13 | Takeda Pharmaceutical Company Limited | Purification of fviii from plasma using silicon oxide adsorption |
| AU2021377336A1 (en) | 2020-11-16 | 2023-07-06 | Prothera Biologics, Inc. | Methods for purifying inter-alpha inhibitor proteins |
| CN119300842A (zh) * | 2022-05-02 | 2025-01-10 | 武田药品工业株式会社 | 通过超滤从血浆制备科恩池浓缩物的方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2390074A (en) * | 1942-02-09 | 1945-12-04 | Research Corp | Protein product and process |
| DK166763B1 (da) | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
| US5055447A (en) * | 1988-07-28 | 1991-10-08 | Genentech, Inc. | Method and compositions for the treatment and prevention of septic shock |
| US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
| FR2711371B1 (fr) | 1993-10-18 | 1995-12-29 | Aetsrn | Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu. |
| DE59509979D1 (de) * | 1995-09-22 | 2002-02-07 | Zlb Bioplasma Ag Bern | Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen |
| AU2002216968A1 (en) | 2000-10-13 | 2002-04-22 | Octapharma Ag | Plasma fraction containing bikunin, method for the production thereof and use of the same |
| US7932365B2 (en) | 2003-11-08 | 2011-04-26 | Pro Thera Biologics, Llc | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| CN101160133B (zh) * | 2004-11-05 | 2013-01-09 | 普罗瑟拉生物公司 | 治疗用途的来自人血浆的内-α抑制剂蛋白质的制备和组合物 |
| ES2595059T3 (es) * | 2007-03-20 | 2016-12-27 | Csl Behring Gmbh | Métodos para la producción a escala industrial de preparados terapéuticos del Factor H del complemento a partir de plasma humano |
| JP5793076B2 (ja) * | 2008-05-28 | 2015-10-14 | プロセラ バイオロジクス， インコーポレイテッド | 血液由来インター−アルファ−阻害タンパク質の調製及び組成物。 |
| WO2011011753A1 (en) | 2009-07-23 | 2011-01-27 | Baxter International Inc. | Manufacture of factor h (fh) and fh-derivatives from plasma |
| AU2010202125B1 (en) * | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| EP2596014B1 (en) | 2010-07-23 | 2018-11-28 | Baxalta GmbH | Manufacture of inter-alpha-inhibitor proteins (iaip) from plasma |
-
2011
- 2011-07-22 EP EP11749976.4A patent/EP2596014B1/en active Active
- 2011-07-22 WO PCT/US2011/045099 patent/WO2012012773A1/en not_active Ceased
- 2011-07-22 ES ES11749976T patent/ES2717177T3/es active Active
- 2011-07-22 AU AU2011280907A patent/AU2011280907B2/en active Active
- 2011-07-22 BR BR112013001753A patent/BR112013001753A2/pt not_active Application Discontinuation
- 2011-07-22 EA EA201390156A patent/EA201390156A1/ru unknown
- 2011-07-22 JP JP2013521858A patent/JP5830096B2/ja not_active Expired - Fee Related
- 2011-07-22 CN CN2011800457670A patent/CN103119058A/zh active Pending
- 2011-07-22 SG SG2013005640A patent/SG187599A1/en unknown
- 2011-07-22 MX MX2013000958A patent/MX2013000958A/es not_active Application Discontinuation
- 2011-07-22 KR KR1020137004453A patent/KR20130093607A/ko not_active Withdrawn
- 2011-07-22 CA CA2806645A patent/CA2806645A1/en not_active Abandoned
- 2011-07-22 US US13/189,390 patent/US8841248B2/en active Active
-
2013
- 2013-02-21 CO CO13035387A patent/CO6680653A2/es not_active Application Discontinuation
-
2014
- 2014-08-19 US US14/463,533 patent/US9505814B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6913066B2 (ja) | 高純度および優れた収率の正確に折り畳まれたエタネルセプト | |
| JP6593721B2 (ja) | 高純度の組換えヒト血清アルブミンを単離、精製するクロマトグラフ法 | |
| KR101683415B1 (ko) | 단일클론항체에 대한 정제 방법 | |
| JP2013528183A5 (enExample) | ||
| JP5830096B2 (ja) | 血漿由来インターα阻害タンパク質（ＩａＩｐ）の製造方法 | |
| CN105899235B (zh) | 用于纯化cys连接的抗体-药物缀合物的方法 | |
| TWI629283B (zh) | 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱 | |
| EP3116527A1 (fr) | Procédé de préparation de protéines plasmatiques humaines | |
| CA2733782A1 (en) | Methods for purifying antibodies using protein a affinity chromatography | |
| JP6742300B2 (ja) | ｒＨｕ−ＧＣＳＦの精製のための新規プロセス | |
| JP4454311B2 (ja) | 生物学的に活性な顆粒球コロニー刺激因子の精製および／または単離方法 | |
| CN112717125A (zh) | 一种纯化蛋白质的方法 | |
| JPH11507033A (ja) | トロンボポイエチンを精製する方法 | |
| HUE027724T2 (hu) | Eljárás G-CSF tisztítására | |
| CN106414495A (zh) | 抗体处理方法 | |
| WO2020234742A1 (en) | Granulocyte colony stimulating factor purification | |
| KR100531670B1 (ko) | 인체 인터페론 알파의 제조방법 | |
| Grellet et al. | An associated process for the purification of immuno globulin g, catalase, superoxide dismutase and albumin from haemolysed human placenta blood | |
| CN115734969A (zh) | 双特异性抗体的纯化 | |
| JPH07278192A (ja) | 人尿腫瘍壊死因子インヒビターの精製法 |